Justin LaVigne

531 total citations
17 papers, 384 citations indexed

About

Justin LaVigne is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Justin LaVigne has authored 17 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Justin LaVigne's work include Neuropeptides and Animal Physiology (11 papers), Receptor Mechanisms and Signaling (7 papers) and Pain Mechanisms and Treatments (6 papers). Justin LaVigne is often cited by papers focused on Neuropeptides and Animal Physiology (11 papers), Receptor Mechanisms and Signaling (7 papers) and Pain Mechanisms and Treatments (6 papers). Justin LaVigne collaborates with scholars based in United States, Poland and Germany. Justin LaVigne's co-authors include John M. Streicher, Attila Keresztes, Val J. Watts, Rennolds S. Ostrom, Carmen Dessauer, Tarsis F. Brust, Roland Seifert, Tally M. Largent‐Milnes, Erika Liktor‐Busa and Wei Lei and has published in prestigious journals such as Physiological Reviews, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Justin LaVigne

17 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin LaVigne United States 8 154 146 118 103 51 17 384
Kushal Kumar India 10 163 1.1× 112 0.8× 82 0.7× 97 0.9× 26 0.5× 11 421
Cindy Barbosa United States 11 217 1.4× 233 1.6× 86 0.7× 115 1.1× 34 0.7× 13 488
Rungtip Soi‐ampornkul Thailand 11 141 0.9× 89 0.6× 83 0.7× 110 1.1× 86 1.7× 20 475
Morteza Samini Iran 13 96 0.6× 211 1.4× 96 0.8× 80 0.8× 26 0.5× 30 448
Bruno Pradier Germany 11 87 0.6× 123 0.8× 151 1.3× 106 1.0× 60 1.2× 24 439
Kwang-Ho Pyun South Korea 14 186 1.2× 91 0.6× 104 0.9× 96 0.9× 36 0.7× 28 586
Yea-Hyun Leem South Korea 15 170 1.1× 89 0.6× 77 0.7× 111 1.1× 21 0.4× 16 430
Molly S. Crowe United States 11 170 1.1× 218 1.5× 388 3.3× 111 1.1× 30 0.6× 13 607
Attila Keresztes United States 14 249 1.6× 263 1.8× 153 1.3× 130 1.3× 53 1.0× 23 508
Ali Hosseini-Sharifabad Iran 12 103 0.7× 84 0.6× 118 1.0× 63 0.6× 28 0.5× 23 339

Countries citing papers authored by Justin LaVigne

Since Specialization
Citations

This map shows the geographic impact of Justin LaVigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin LaVigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin LaVigne more than expected).

Fields of papers citing papers by Justin LaVigne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin LaVigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin LaVigne. The network helps show where Justin LaVigne may publish in the future.

Co-authorship network of co-authors of Justin LaVigne

This figure shows the co-authorship network connecting the top 25 collaborators of Justin LaVigne. A scholar is included among the top collaborators of Justin LaVigne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin LaVigne. Justin LaVigne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhu, Hu, Jason M. Conley, Karavadhi Surendra, et al.. (2025). Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesity. European Journal of Medicinal Chemistry. 295. 117794–117794. 2 indexed citations
2.
LaVigne, Justin, et al.. (2023). Pain-related behavioral and electrophysiological actions of dynorphin A (1-17). Molecular Pain. 19. 814387872–814387872. 2 indexed citations
3.
LaVigne, Justin & Sascha R.A. Alles. (2022). CCK2 receptors in chronic pain. SHILAP Revista de lepidopterología. 11. 100092–100092. 9 indexed citations
4.
Ptak, Christopher P., et al.. (2022). Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotype. Frontiers in Pharmacology. 13. 977742–977742. 3 indexed citations
5.
Scott, Jason A., Michael P. Hayes, Justin LaVigne, et al.. (2022). Optimization of a Pyrimidinone Series for Selective Inhibition of Ca 2+ /Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic Pain. Journal of Medicinal Chemistry. 65(6). 4667–4686. 4 indexed citations
6.
LaVigne, Justin, et al.. (2021). Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific Reports. 11(1). 8232–8232. 80 indexed citations
7.
Liktor‐Busa, Erika, Attila Keresztes, Justin LaVigne, John M. Streicher, & Tally M. Largent‐Milnes. (2021). Analgesic Potential of Terpenes Derived from Cannabis sativa. Pharmacological Reviews. 73(4). 1269–1297. 45 indexed citations
8.
LaVigne, Justin, Tarsis F. Brust, Roland Seifert, et al.. (2021). Physiological roles of mammalian transmembrane adenylyl cyclase isoforms. Physiological Reviews. 102(2). 815–857. 74 indexed citations
9.
Lee, Yeon Sun, Justin LaVigne, G Molnár, et al.. (2021). Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism. Biomedicines. 9(6). 625–625. 7 indexed citations
10.
LaVigne, Justin, et al.. (2020). In Defense of the “Entourage Effect”: Terpenes Found in Cannabis sativa Activate the Cannabinoid Receptor 1 In Vitro. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
11.
LaVigne, Justin, et al.. (2020). The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. Pharmacological Reports. 72(2). 465–471. 5 indexed citations
12.
LaVigne, Justin, et al.. (2020). In Defense of the “Entourage Effect”: Terpenes Found in Cannabis sativa Activate the Cannabinoid Receptor 1 In Vivo. The FASEB Journal. 34(S1). 1–1. 7 indexed citations
13.
Lei, Wei, et al.. (2017). Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.. PubMed. 90(1). 97–110. 34 indexed citations
14.
Xie, Jennifer Y., Milena De Felice, Caroline Machado Kopruszinski, et al.. (2017). Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. Cephalalgia. 37(8). 780–794. 76 indexed citations
15.
Edwards, Katie A., et al.. (2016). (285) Phosphatidylethanolamine-binding protein regulates Mu opioid receptor induced βarrestin2 recruitment and downstream signaling. Journal of Pain. 17(4). S47–S47. 1 indexed citations
16.
Lee, Yeon Sun, Justin LaVigne, Peg Davis, et al.. (2016). Structure–Activity Relationships of [des-Arg7]Dynorphin A Analogues at the κ Opioid Receptor. Journal of Medicinal Chemistry. 59(22). 10291–10298. 11 indexed citations
17.
Stevenson, Glenn W., Justin LaVigne, Denise Giuvelis, et al.. (2015). The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. Pharmacology Biochemistry and Behavior. 132. 49–55. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026